Study of serotonin in neuropsychiatric disorders.
作者信息
Van Woert M H, Magnussen I, Lowe Y H, Hwang E C
出版信息
J Histochem Cytochem. 1982 Aug;30(8):824-7. doi: 10.1177/30.8.6181125.
PMID:6181125
Abstract
摘要
相似文献
1
Study of serotonin in neuropsychiatric disorders.
J Histochem Cytochem. 1982 Aug;30(8):824-7. doi: 10.1177/30.8.6181125.
2
Serotonin and myoclonus.
Monogr Neural Sci. 1976;3:71-80.
3
Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
Trans Am Neurol Assoc. 1976;101:48-52.
4
Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
Neurology. 1975 Feb;25(2):135-40. doi: 10.1212/wnl.25.2.135.
5
[Serotoninergic conception of myoclonic syndromes. (Review)].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1979;79(6):797-803.
6
Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
N Engl J Med. 1977 Jan 13;296(2):70-5. doi: 10.1056/NEJM197701132960203.
7
HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
J Neurol Sci. 1973 Apr;18(4):435-41. doi: 10.1016/0022-510x(73)90137-8.
8
Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.
J Autism Dev Disord. 1979 Mar;9(1):95-103. doi: 10.1007/BF01531296.
9
The indoleamine hypothesis of depression: an overview and pilot study.
Dis Nerv Syst. 1977 Aug;38(8):646-53.
10
A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
Mol Genet Metab. 2001 Jun;73(2):179-87. doi: 10.1006/mgme.2001.3187.
Zotero 插件